Oncternal Therapeutics (ONCT)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	13.08 mm	13.08 mm	13.08 mm	13.08 mm	13.08 mm	13.08 mm
Cash burn (monthly)	(no burn)	153.83 k	2.89 mm	3.00 mm	2.32 mm	2.22 mm
Cash used (since last report)	n/a	638.44 k	12.01 mm	12.44 mm	9.62 mm	9.21 mm
Cash remaining	n/a	12.44 mm	1.07 mm	642.49 k	3.46 mm	3.87 mm
Runway (months of cash)	n/a	80.9	0.4	0.2	1.5	1.7

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

ONCT institutional ownership history Ownership history

16.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	26	3	+766.7%
Opened positions	23	3	+666.7%
Closed positions	0	2	EXIT
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	3.66 bn	4.02 mm	+90819.1%
Total shares	483.10 k	447.00	+107975.2%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Vanguard	143.04 k	$1.09 bn	NEW
Millennium Management	102.94 k	$782.31 mm	NEW
BLK BlackRock	39.28 k	$298.51 mm	NEW
Quantum Private Wealth	26.90 k	$204.46 mm	NEW
Dimensional Fund Advisors	26.30 k	$199.87 mm	NEW
Geode Capital Management	25.88 k	$196.71 mm	NEW
Pasadena Private Wealth	25.00 k	$190.00 mm	NEW
Richmond Brothers	24.70 k	$187.69 mm	NEW
Renaissance Technologies	17.20 k	$130.76 mm	NEW
Brighton Jones	16.92 k	$128.62 mm	NEW

Largest transactions	Shares	Bought/sold	Change
Vanguard	143.04 k	+143.04 k	NEW
Millennium Management	102.94 k	+102.94 k	NEW
BLK BlackRock	39.28 k	+39.28 k	NEW
Quantum Private Wealth	26.90 k	+26.90 k	NEW
Dimensional Fund Advisors	26.30 k	+26.30 k	NEW
Geode Capital Management	25.88 k	+25.88 k	NEW
Pasadena Private Wealth	25.00 k	+25.00 k	NEW
Richmond Brothers	24.70 k	+24.70 k	NEW
Renaissance Technologies	17.20 k	+17.20 k	NEW
Brighton Jones	16.92 k	+16.92 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ONCT insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
20 Jun 24	Wills Robert James	Stock Options Common Stock	Grant	Acquire A	No	No	8.1	2,200	17.82 k	2,200
20 Jun 24	Larue William R	Stock Options Common Stock	Grant	Acquire A	No	No	8.1	2,200	17.82 k	2,200
20 Jun 24	Hale David F	Stock Options Common Stock	Grant	Acquire A	No	No	8.1	3,300	26.73 k	3,300
20 Jun 24	Theuer Charles	Stock Options Common Stock	Grant	Acquire A	No	No	8.1	2,200	17.82 k	2,200
20 Jun 24	Rosemary Mazanet	Stock Options Common Stock	Grant	Acquire A	No	No	8.1	2,200	17.82 k	2,200

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

12 Health Care Stocks Moving In Monday's Pre-Market Session

25 Nov 24

Gold Down Over 3%; Rigetti Computing Shares Spike Higher

25 Nov 24

Crude Oil Down 3%; Chicago Fed National Activity Index Falls In October

25 Nov 24

Dow Surges Over 300 Points; Bath & Body Works Posts Upbeat Earnings

25 Nov 24

On November 22, Oncternal Therapeutics Announced That Nasdaq Plans To Delist Its Stock On December 3, Nasdaq Classified The Company As "Public Shell," Following Its Decision To Lay Off Employees And Explore Strategic Alternatives-Filing

25 Nov 24